Zevra Therapeutics, Inc. (ZVRA) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$8.73
Day's range
$9.12

Zevra Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 4.51 M $40.38 M   11.64% 8.06%
WOODLINE PARTNERS LP 02/17/2026 3.45 M $30.92 M   -0.73% 6.17%
VANGUARD GROUP INC 01/29/2026 3.31 M $29.61 M   7.19% 5.91%
FMR LLC 02/17/2026 2.39 M $21.45 M   46.43% 4.28%
NANTAHALA CAPITAL MANAGEMENT, LLC 02/13/2026 1.77 M $15.88 M   -10.14% 3.17%
STATE STREET CORP 02/13/2026 1.48 M $13.29 M   3.90% 2.65%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 1.34 M $12.02 M   3.18% 2.40%
CAPTION MANAGEMENT, LLC 02/17/2026 1.20 M $10.76 M   4.49% 2.15%
MORGAN STANLEY 02/13/2026 1.16 M $10.37 M   108.28% 2.07%
MILLENNIUM MANAGEMENT LLC 02/17/2026 1.13 M $10.16 M   9.57% 2.03%
CAPTION MANAGEMENT, LLC 02/17/2026 1.10 M $9.87 M   10.11% 1.97%
LEGAL & GENERAL GROUP PLC 02/09/2026 1.10 M $9.84 M   4.23% 1.96%
683 CAPITAL MANAGEMENT, LLC 02/17/2026 905.00 K $8.11 M   -7.18% 1.62%
ROYCE & ASSOCIATES LP 02/09/2026 865.82 K $7.76 M   25.26% 1.55%
D. E. SHAW & CO., INC. 02/17/2026 863.75 K $7.74 M   19.00% 1.54%
CITADEL ADVISORS LLC 02/17/2026 842.85 K $7.55 M   339.45% 1.51%
TUDOR INVESTMENT CORP ET AL 02/17/2026 692.10 K $6.20 M   54.52% 1.24%
MARSHALL WACE, LLP 02/13/2026 669.74 K $6.00 M   -26.59% 1.20%
RETIREMENT PLANNING CO OF NEW ENGLAND, INC. 01/28/2026 662.98 K $5.94 M   10.35% 1.18%
GOLDMAN SACHS GROUP INC 03/25/2026 588.70 K $5.27 M   -22.72% 1.05%
KINGDON CAPITAL MANAGEMENT, L.L.C. 02/17/2026 585.07 K $5.24 M   -9.99% 1.05%
STONEPINE CAPITAL MANAGEMENT, LLC 02/13/2026 569.09 K $5.10 M   -29.74% 1.02%
JANE STREET GROUP, LLC 02/12/2026 563.91 K $5.05 M   163.26% 1.01%
CAPTION MANAGEMENT, LLC 02/17/2026 540.11 K $4.84 M   5.89% 0.97%
SCHRODER INVESTMENT MANAGEMENT GROUP 02/13/2026 506.03 K $4.46 M   22.66% 0.90%
NORTHERN TRUST CORP 02/17/2026 418.12 K $3.75 M   -4.86% 0.75%
JPMORGAN CHASE & CO 02/11/2026 412.26 K $3.69 M   -6.09% 0.74%
STRATOS WEALTH PARTNERS, LTD. 01/20/2026 409.00 K $3.66 M   78.60% 0.73%
QUBE RESEARCH & TECHNOLOGIES LTD 02/17/2026 356.24 K $3.19 M   16.23% 0.64%
MYSTIC ASSET MANAGEMENT, INC. 01/28/2026 346.53 K $3.10 M   -0.04% 0.62%
SQUAREPOINT OPS LLC 02/13/2026 317.07 K $2.84 M   18.27% 0.57%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 293.10 K $2.63 M   -75.69% 0.52%
UBS GROUP AG 01/29/2026 285.49 K $2.56 M   30.90% 0.51%
ADAGE CAPITAL PARTNERS GP, L.L.C. 02/17/2026 275.00 K $2.46 M   -87.64% 0.49%
TREXQUANT INVESTMENT LP 02/17/2026 209.70 K $1.88 M   -30.76% 0.37%
JANNEY MONTGOMERY SCOTT LLC 02/11/2026 202.88 K $1.82 M   10.44% 0.36%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 197.20 K $1.77 M   13.79% 0.35%
TFG ASSET MANAGEMENT GP LTD 02/17/2026 192.52 K $1.72 M   100.00% 0.34%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 181.13 K $1.62 M   18.92% 0.32%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 180.62 K $1.62 M   14.49% 0.32%
KOVACK ADVISORS, INC. 02/17/2026 175.33 K $1.57 M   0.03% 0.31%
BANK OF NEW YORK MELLON CORP 02/10/2026 174.16 K $1.56 M   38.40% 0.31%
WELLINGTON MANAGEMENT GROUP LLP 02/17/2026 170.31 K $1.53 M   -9.06% 0.30%
CITADEL ADVISORS LLC 02/17/2026 157.20 K $1.41 M   53.97% 0.28%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 154.47 K $1.38 M   100.00% 0.28%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2026 151.42 K $1.36 M   196.62% 0.27%
ACADIAN ASSET MANAGEMENT LLC 02/10/2026 149.64 K $1.34 M   83.45% 0.27%
BANK OF AMERICA CORP /DE/ 02/17/2026 146.36 K $1.31 M   -49.19% 0.26%
NUVEEN, LLC 02/12/2026 143.13 K $1.28 M   -6.47% 0.26%
HENNION & WALSH ASSET MANAGEMENT, INC. 01/14/2026 139.59 K $1.25 M   100.00% 0.25%

Zevra Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 197 institutional investors and hedge funds held shares of Zevra Therapeutics Inc. The most heavily invested institutionals were:

AIGH Capital Management LLC: 1.2 M

UBS Group AG: 422,048

Stratos Wealth Partners, LTD.: 408,000

FLPUTNAM INVESTMENT MANAGEMENT CO: 350,501

Janney Montgomery Scott LLC: 236,834

Nuveen, LLC: 192,588

68.18% of Zevra Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 43.22 M shares in the last 24 months. This purchase volume represents approximately $394.13 M in transactions.